Fed. Circ. Upholds Injunction On Generic Pulmicort

Law360, New York (November 1, 2010, 7:07 PM EDT) -- A federal appeals court on Monday affirmed a ruling that granted AstraZeneca Pharmaceuticals LP a preliminary injunction in a suit to prevent Apotex Inc. from launching a generic version of children's asthma treatment Pulmicort Respules.

A lower court's judge did not abuse her discretion in granting the injunction, said two judges of the U.S. Court of Appeals for the Federal Circuit, with one judge, William Bryson, dissenting from that part of the ruling.

All three judges on the panel also upheld the lower court’s ruling that...
To view the full article, register now.